Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s43441-020-00235-y http://scihub22266oqcxt.onion/10.1007/s43441-020-00235-y 33111176!7590989!33111176     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Ther+Innov+Regul+Sci 2021 ; 55 (1): 247-249 Nephropedia Template TP {{tp|p=33111176|t=2021. Patient Contribution to the Development and Safe Use of Medicines During the Covid-19 Pandemic |pdf=|usr=}}{{33111176}} gab.com Text Patient Contribution to the Development and Safe Use of Medicines During the Covid-19 Pandemic JO: Ther Innov Regul Sci http://www.kidney.de/pget.php?&tw=1&pmid=33111176 #FOAvip COVID-19 has catapulted the issue of the patient voice in healthcare and healthcare policy to the front of the global agenda. The world population has been affected with varying government-required risk mitigation measures including social distancing, national, regional and local "lock down" quarantines, and the wearing of masks along with diligent handwashing. Clearly, not all of these measures are possible in every country due to a lack of resources and healthcare infrastructure, and it will surely be patients who will suffer the most as a result. This issue must be dealt with responsibly on the local level by all countries and patients cooperating with and supporting overwhelmed healthcare systems and aiding the planned implementation of mitigation measures. If not, pockets of SARS-CoV-2 will remain in these regions with continuous suffering of their populations. This is critical as we still do not fully understand the clinical, pathological and epidemiological attributes of SARS-CoV-2; the longer it stays embedded and circulating, the possibility of mutation into a deadlier virus remains along with further waves of epidemics. Twit Text FOAVip Patient Contribution to the Development and Safe Use of Medicines During the Covid-19 Pandemic ????Ther Innov Regul Sci http://www.kidney.de/pget.php?&tw=1&pmid=33111176 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33111176 #FOAvip English Wikipedia <ref>{{Cite pmid|33111176}}</ref> Patient Contribution to the Development and Safe Use of Medicines During the Covid-19 Pandemic #MMPMID33111176 Pitts PJ; Houyez F Ther Innov Regul Sci 2021[Jan]; 55 (1): 247-249 PMID33111176show ga COVID-19 has catapulted the issue of the patient voice in healthcare and healthcare policy to the front of the global agenda. The world population has been affected with varying government-required risk mitigation measures including social distancing, national, regional and local "lock down" quarantines, and the wearing of masks along with diligent handwashing. Clearly, not all of these measures are possible in every country due to a lack of resources and healthcare infrastructure, and it will surely be patients who will suffer the most as a result. This issue must be dealt with responsibly on the local level by all countries and patients cooperating with and supporting overwhelmed healthcare systems and aiding the planned implementation of mitigation measures. If not, pockets of SARS-CoV-2 will remain in these regions with continuous suffering of their populations. This is critical as we still do not fully understand the clinical, pathological and epidemiological attributes of SARS-CoV-2; the longer it stays embedded and circulating, the possibility of mutation into a deadlier virus remains along with further waves of epidemics. |*COVID-19 Drug Treatment[MESH] |*Patient Participation[MESH] |*SARS-CoV-2[MESH] |COVID-19/epidemiology[MESH] |Communication[MESH] |Humans[MESH]Patient Contribution to the Development and Safe Use of Medicines Duri(epmc).pdf DeepDyve Pubget Overpricing